Please login to the form below

Not currently logged in
Email:
Password:

The Royal Marsden

This page shows the latest The Royal Marsden news and features for those working in and with pharma, biotech and healthcare.

Call for genetic tests to bring personalised medicine to children with cancer

Call for genetic tests to bring personalised medicine to children with cancer

Experts at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust want the NHS to dramatically scale up access to genetic sequencing for children, so that doctors ... Professor Louis Chesler. Professor Louis Chesler,

Latest news

  • Innovating patient care Innovating patient care

    His institution is also part of a vanguard project with London hospitals the Royal Marsden and UCLH. “ ... If we get it right between the Christie, the Royal Marsden and UCLH, it will hopefully provide a template.”.

  • BMS launches Opdivo for lung cancer in UK BMS launches Opdivo for lung cancer in UK

    Commenting on the launch for lung cancer, Dr Sanjay Popat of the Royal Marsden hospital said: "This group of patients with relapsed squamous-type lung cancer represents a considerable unmet medical ... need in the UK, as chemotherapy has been their main

  • NHS sponsors charity on metastatic breast cancer study NHS sponsors charity on metastatic breast cancer study

    With funding from Walk the Walk and sponsorship by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research (ICR), London, the LEGACY study allows patients with secondary breast ... Peter Barry, consultant oncoplastic breast surgeon at

  • Personalised cancer medicines showcased in BBC investigation Personalised cancer medicines showcased in BBC investigation

    efficacy. In the Panorama investigation, the editorial team spent two years filming at the Royal Marsden Hospital and its Institute of Cancer Research arm in London, and followed a number of ... Doctors at the Royal Marsden used Novartis' Zykadia

  • Boehringer's oncology unit scores first EU approval Boehringer's oncology unit scores first EU approval

    cancers associated with a high mortality such as lung cancer", said Dr Sanjay Popat of the Royal Marsden NHS Foundation Trust in the UK, and lead investigator in Giotrif's pivotal ... Boehringer has plans to extend the indications for Giotrif into breast

More from news
Approximately 2 fully matching, plus 23 partially matching documents found.

Latest from PMHub

  • Leading the conversation in oncology

    We have fostered unique working partnerships with organisations such as The Royal Marsden Hospital and e cancer, Europe’ s leading oncology channel, and are proud of our long-standing role as ... The Royal Marsden Hospital NHS Foundation Trust, London.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Future Market Insights

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics